NewGenIvf Group Limited (NASDAQ:NIVF) Short Interest Up 312.0% in December

NewGenIvf Group Limited (NASDAQ:NIVF) saw a significant increase in short interest in December. As of December 15th, there was short interest totaling 223,462 shares, an increase of 312.0% from the November 30th total of 54,240 shares. Based on an average daily volume of 2,137,374 shares, the days-to-cover ratio is currently 0.1 days. Currently, 55.4% of the company’s stock are short sold. Currently, 55.4% of the company’s stock are short sold. Based on an average daily volume of 2,137,374 shares, the days-to-cover ratio is currently 0.1 days.

NewGenIvf Group Stock Performance

Shares of NASDAQ:NIVF traded down $0.01 on Friday, reaching $0.80. The company’s stock had a trading volume of 88,743 shares, compared to its average volume of 218,827. NewGenIvf Group has a 52-week low of $0.77 and a 52-week high of $2,450.00. The stock’s 50-day moving average is $2.55 and its two-hundred day moving average is $10.90. The company has a debt-to-equity ratio of 0.17, a current ratio of 3.43 and a quick ratio of 3.37.

Analyst Ratings Changes

NIVF has been the topic of a number of recent analyst reports. Wall Street Zen raised shares of NewGenIvf Group to a “hold” rating in a research report on Saturday, December 6th. Weiss Ratings restated a “sell (d)” rating on shares of NewGenIvf Group in a research note on Friday, October 31st. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company has a consensus rating of “Sell”.

NewGenIvf Group Company Profile

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.